Milestones

Our most significant achievement lies in the realm of Research & Development. We are the partner of choice, offering robust technical support and custom-made process innovations to the market with swiftness, competence, and cost-effectiveness.

At SAI Parenterals, we are not just making pharmaceuticals, we are creating healthier lives
and brighter future. Our commitment to excellence, innovation, and affordability is the driving force behind everything we do.

1988
1988

REVAT ESTABLISHMENT

The company was founded by
Mr. & Mrs. K Tata Rao Garufor the OSD (Tabs/Cabs/Liq)

2015
2015

TAKE OVER -SAI PARENTERALS 2 UNITS AT IDA JEEDIMETLA

Took new Sai Parenterals & did the
necessary modifications to suit the
expected regulatory requirements.

"
FEB 2022
FEB 2022

TAKE OVER OF A TGA APPROVED FACILITY @ IDA BHONGIR

It was in the Slump sale model of
take over where there was change
in the management, & we retained
all the accreditations and the team
with the current business then.

MARCH 2022
MARCH 2022

SAI REACHED A TURNOVER OF OVER 100 CRS AND WITH REVAT REACHED TO 170 CRS

Once the 100 cr milestone was touched
the Expansion as ealrier planned has
began by Look out for creating a mark in
the Export Market.

AUGUST 2022
AUGUST 2022

Take over of the medreich -
Cephalosporins Unit at IDA BOLLARAM

MARCH 2023
MARCH 2023

TGA-Australia Renewed
for our Unit 3 @ IDA- Bhongir

Forging Ahead to Achieve Greater Milestones.

Continuous astronomical
growth rate of our Global
Presence